http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6245521-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39ae96c0ecc22ff90ff986371a3cea0f |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate | 1985-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e400a4475f7cd0bb99680249be8fe0cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3a9a115d1077b33c7ff3624abee5a74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeacac08424f42faf0844aa7cfb2b8b7 |
publicationDate | 1987-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-S6245521-A |
titleOfInvention | Oil suspension agent for rectal infusion |
abstract | PURPOSE: To obtain the titled agent for rectal infusion, storable at room temperature, administrable at an arbitrarily adjustable dose without staining the hand and giving little unagreeable feeling to the body, by suspending a water-soluble drug and a gelling agent in an oily substance using a dispersing agent. n CONSTITUTION: (A) A water-soluble drug usually having low absorbability in the body, e.g. cephalosporin antibiotic substance, antitumor agent, etc., and (B) a gelling agent, e.g. a water-soluble polymer such as carboxyvinyl polymer, xanthan gum, etc., are dispersed in an oily substance in the presence of (C) a dispersing agent such as glyceryl monofatty acid ester, polyoxyethylene castor oil derivative, etc., especially a surfactant having low HLB value. The amounts of the components A, B and C are 0.01W30%, 0.1W10% and 0.1W10%, respectively. When the drug is hardly absorbable in the body by oral administration, the agent is preferably compounded with 0.1W10% absorbefacient (e.g. bile acid, fatty acid, etc.). n COPYRIGHT: (C)1987,JPO&Japio |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011503217-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016537352-A |
priorityDate | 1985-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.